The US FDA New Drug Approvals in April 2025

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of April 2025 The US FDA has approved a total of 3 new drug including 1 new molecular entity and 2 Biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drug was Johnson & Johnson’s…

ByDipanshu DixitMay 13, 2025

INSIGHTS+

Disease of the Month – Myocardial infarction (MI)

Shots: Myocardial infarction (MI), colloquially known as a heart attack, occurs when blood flow to the heart is severely reduced or blocked, causing tissue damage or mortality due to lack of oxygen PharmaShots' Disease of the Month report aims to familiarize the general population with conditions impacting communities worldwide. The report outlines disease characteristics, types,…

ByDipanshu DixitApril 30, 2025

INSIGHTS+

EMA Marketing Authorization of New Drugs in March 2025

Shots: The EMA’s CHMP has granted positive opinions and approvals to 2 Biologics and 1 New Chemical Entity in March 2025, leading to treatments for patients and advances in the healthcare industry The major highlighted drugs were Merck’s Capvaxive to treat invasive pneumococcal disease PharmaShots has compiled a list of 3 drugs that have been…

ByDipanshu DixitApril 22, 2025

INSIGHTS+

The US FDA New Drug Approvals in March 2025

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of March 2025 The US FDA has approved a total of 2 new drug including 2 new molecular entities leading to the treatment of patients and advances in the healthcare industry The major highlighted drug was GSK’s Blujepa securing approval for treating…

ByDipanshu DixitApril 15, 2025

INSIGHTS+

Disease of the Month – Dry age-related macular degeneration (dAMD)

Shots: Dry age-related macular degeneration (dAMD) is a common eye disorder that gradually damages the macula, the central part of the retina, responsible for sharp vision Our Disease of the Month report covers epidemiology, market size, current management strategies, emerging therapeutic options, and the role of patient advocacy groups. Additionally, we highlight the key industry…

ByDipanshu DixitDecember 24, 2024

INSIGHTS+

Disease of the Month – Gastroparesis

Shots: Gastroparesis is a chronic gastrointestinal disorder characterized by delayed gastric emptying, leading to symptoms such as nausea, vomiting, bloating, and early satiety. This condition significantly affects patients' quality of life, posing challenges for diagnosis and treatment. Our Disease of the Month report covers epidemiology, market size, current management strategies, emerging therapeutic options, and the…

ByDipanshu DixitNovember 19, 2024

VIEWPOINTS

AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

Shots: Recently, AstraZeneca presented findings from the real-world IMPACT CKD study, which evaluated the multifaceted impact of CKD on patients, healthcare systems, and broader society, projecting future implications through 2032. The study emphasizes the importance of mitigating the economic burden on healthcare by implementing early, targeted screening, diagnosis, and treatment for CKD. In collaboration with…

BySaurabh ChaubeyOctober 28, 2024

VIEWPOINTS

Establishing Safe Treatment: Dr. Robert Rifikin from Rocky Mountain Cancer Centers in Conversation with PharmaShots

Shots: There is an average lifetime risk of getting multiple myeloma of about 1 in 103 men and 1 in 131 women in the United States Treatment of multiple myeloma using fourth-line therapy like teclistamab can induce issues like cytokine release syndrome (CRS) and neurotoxicity Today, at PharmaShots we have Dr. Robert Rifikin from Rocky…

BySaurabh ChaubeyAugust 5, 2024

TOP 20

Top 20 Innovative Digital Therapeutics Companies of 2024

Shots:New-age technologies are transforming the healthcare industry continuously. By leveraging digital health platforms, AI-powered apps, and other innovative solutions, there is a significant enhancement in diagnosis, treatment, and preventionWith a global market revenue of $180.2B in 2023, the market is projected to reach $549.7B by 2028, registering a CAGR of 25 percent. This…

ByPrince GiriJune 27, 2024

THOUGHTSPOT

Clinical Trial to Study Effectiveness of Cancer Treatment Administered 2024

There are tons of clinical trials taking place at this moment. It’s a nasty disease and it’s important to figure out different ways to diagnose it, treat it, and, if possible, prevent it. 2024 brings on innovations in this field.It can probably shed light on how cancer can become more treatable and not such…

ByJack TurnerJune 20, 2024

The US FDA New Drug Approvals in April 2025

Disease of the Month – Myocardial infarction (MI)

EMA Marketing Authorization of New Drugs in March 2025

The US FDA New Drug Approvals in March 2025

Disease of the Month – Dry age-related macular degeneration (dAMD)

Disease of the Month – Gastroparesis

AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots

Establishing Safe Treatment: Dr. Robert Rifikin from Rocky Mountain Cancer Centers in Conversation with PharmaShots

Top 20 Innovative Digital Therapeutics Companies of 2024

Clinical Trial to Study Effectiveness of Cancer Treatment Administered 2024

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter